Notification of Tuberculosis (TB) cases from the private sector to state public health officials is a challenge. This helps to better practices in terms of Standard TB Care which include helping the patients to get right diagnosis, treatment, Follow up & facilitates social support systems. From 2009-2014, only 8.4% of total TB cases from the private sector were notified, with a majority being unaccounted for in the country. Multidrug resistant (MDR) TB is a major challenge which needs to be addressed by all the stake holders.
The goal was to assess the burden of TB in private sector, determine the site of disease and estimate drug resistance.
A single centre prospective study was conducted in a tertiary care hospital. Patients over 18years diagnosed with TB from July 2015 to May 2016 were included. Transplant patients and those with hematologic malignancies were excluded. Demographics, diagnostic tests, drug resistance patterns were recorded and analyzed.
Two hundred and fifty six (mean age 18-45years) cases were studied.
|PREVIOUS HISTORY OF TB|
|1st episode||232 (93.6%)|
|Diabetes mellitus||31 (12.1%)|
Ziehl Neelsen stain
|Bactec acid fast bacilli culture|
|Radiology + Pathology||104|
|SITE OF DISEASE|
|Isoniazid + Rifampicin + Ethambutol||10 (66.6%)|
|Isoniazid + Rifampicin||1 (6.6%)|
|Isoniazid + Para amino salicylic acid||1 (6.6%)|
MDR TB (n=15)
|Central nervous system||1|
Tuberculosis burden in India is increasing inspite of lot of efforts made to contain it. Diabetes mellitus is one of the risk factors for TB. Extra pulmonary TB was more commonly encountered. Gene Xpert testing is being increasingly used. Drug resistant TB was observed at 5.85%. Isoniazid resistance may be under reported as Isoniazid testing is not routinely performed. Clinicians in the private setting need to improve the reporting of TB.
S. A. Allam, None
S. P. Sesha, None
S. K. Boinapalli, None
A. Trivedi, None
R. Rao, None
R. Sharma, None
A. Farheen, None
S. Chadha, None